AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation
- PMID: 33742148
- PMCID: PMC8144419
- DOI: 10.1038/s41416-021-01302-3
AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation
Abstract
Smartphone applications ("apps") with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers' claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Ipsos-MORI. Technology tracker Q3. https://www.ipsos.com/sites/default/files/ct/publication/documents/2018-... (2018).
-
- Flaten, H. K., St Claire, C., Schlager, E., Dunnick, C. A. & Dellavalle R. P. Growth of mobile applications in dermatology—2017 update. Dermatol Online J.24, 13030/qt3hs7n9z6 (2018) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
